Search this site
Embedded Files
Skip to main content
Skip to navigation
東京理科大学 薬学部 分子薬理学
Home
Research
Osteoporosis therapeutic drugs
Cancer genomics
Juvenile nephronophthisis disease modeling
Gprc5a
Ctdnep1 in the osteoclats
Cpeb4 in splicing
GSDMD (Gorham-Stout disease)
DiGeorge syndrome
Cpeb4
NPHP1(juvenile nephronophthisis)
Ctdnep1 in the ovary
Ctdnep1
Pfn1
Cnot3
Adrb2
Equipment
Publications
Presentations
Team 2025
Journal Club
Supporters
Recruitment
Tomoya Shimizu
Degree Thesis
Contact
Facility
東京理科大学 薬学部 分子薬理学
Home
Research
Osteoporosis therapeutic drugs
Cancer genomics
Juvenile nephronophthisis disease modeling
Gprc5a
Ctdnep1 in the osteoclats
Cpeb4 in splicing
GSDMD (Gorham-Stout disease)
DiGeorge syndrome
Cpeb4
NPHP1(juvenile nephronophthisis)
Ctdnep1 in the ovary
Ctdnep1
Pfn1
Cnot3
Adrb2
Equipment
Publications
Presentations
Team 2025
Journal Club
Supporters
Recruitment
Tomoya Shimizu
Degree Thesis
Contact
Facility
More
Home
Research
Osteoporosis therapeutic drugs
Cancer genomics
Juvenile nephronophthisis disease modeling
Gprc5a
Ctdnep1 in the osteoclats
Cpeb4 in splicing
GSDMD (Gorham-Stout disease)
DiGeorge syndrome
Cpeb4
NPHP1(juvenile nephronophthisis)
Ctdnep1 in the ovary
Ctdnep1
Pfn1
Cnot3
Adrb2
Equipment
Publications
Presentations
Team 2025
Journal Club
Supporters
Recruitment
Tomoya Shimizu
Degree Thesis
Contact
Facility
CTDNEP1 の低発現は膵がんにおける予後不良を予測し、免疫調節と関連している
Low CTDNEP1 Expression Predicts Poor Prognosis and Is Associated With Immune Modulation in Pancreatic Cancer
Nii and Hayata
,
Cancer Genomics Proteomics. 2026
本研究は、新居真由香(当時博士後期課程
2
年)が中心に行ったものです。
プレスリリースは
こちら
。
Google Sites
Report abuse
Page details
Page updated
Google Sites
Report abuse